incidence of pancreatitis with glp 1 GLP-1 receptor agonists and the risk acute pancreatitis: a living systematic review and meta-analysis Updates in Medicine | GLP-1s
Description
How should I choose between a dual agonist and a triple agonist
Researchers are investigating the potential of these drugs further
The existing GLP-1 pill, Wegovy, is made of a peptide, a protein-based molecule
Retatrutide administered once weekly subcutaneously for 12 weeks resulted in a dose-dependent placebo-adjusted weight loss of up to 8.96 kg in the highest dose group and a placebo-adjusted HbA1c reduction of up to 1.6% in a phase II trial in individuals with T2DM [125]
